Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single low-dose intravenous erythropoietin plus intravenous iron in elderly hip fracture surgery: effect on postoperative blood loss and transfusion
TCTR20180606005Phase 1Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial in hip fracture comparing IV erythropoietin + IV iron with Placebo + IV iron (2 arms). Primary endpoints: Postoperative blood loss and Blood transfusion requirement. Started Jan 2013; status: completed.
02
Drugs
erythropoietin
03
Conditions
hip fracture
Beyond the preview
Go deeper on TCTR20180606005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180606005.